Halozyme Therapeutics, Inc. (HALO): Price and Financial Metrics
HALO Price/Volume Stats
| Current price | $39.12 | 52-week high | $45.00 |
| Prev. close | $38.97 | 52-week low | $29.85 |
| Day low | $38.82 | Volume | 620,516 |
| Day high | $39.70 | Avg. volume | 1,244,815 |
| 50-day MA | $39.65 | Dividend yield | N/A |
| 200-day MA | $38.82 | Market Cap | 4.97B |
HALO Stock Price Chart Interactive Chart >
Halozyme Therapeutics, Inc. (HALO) Company Bio
Halozyme Therapeutics is a biotechnology company focused on developing and commercializing novel oncology therapies that target the tumor microenvironment. The company was founded in 1998 and is based in San Diego, California.
Latest HALO News From Around the Web
Below are the latest news stories about HALOZYME THERAPEUTICS INC that investors may wish to consider to help them evaluate HALO as an investment opportunity.
Insider Sell Alert: SVP, Chief Technical Officer Michael Labarre Sells 20,000 Shares of ...Halozyme Therapeutics Inc (NASDAQ:HALO), a biopharmaceutical company known for its novel enzyme technology that targets the extracellular matrix, has recently witnessed a significant insider sell transaction. |
3 Reasons Growth Investors Will Love Halozyme Therapeutics (HALO)Halozyme Therapeutics (HALO) possesses solid growth attributes, which could help it handily outperform the market. |
Why Halozyme Therapeutics (HALO) is a Top Growth Stock for the Long-TermWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. |
Why Is Halozyme Therapeutics (HALO) Up 2.8% Since Last Earnings Report?Halozyme Therapeutics (HALO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Here's Why Halozyme Therapeutics (HALO) is a Strong Value StockWondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. |
HALO Price Returns
| 1-mo | -3.22% |
| 3-mo | 13.36% |
| 6-mo | 17.20% |
| 1-year | 16.53% |
| 3-year | -22.47% |
| 5-year | 141.18% |
| YTD | 5.84% |
| 2023 | -35.04% |
| 2022 | 41.51% |
| 2021 | -5.85% |
| 2020 | 140.89% |
| 2019 | 21.19% |
Continue Researching HALO
Want to see what other sources are saying about Halozyme Therapeutics Inc's financials and stock price? Try the links below:Halozyme Therapeutics Inc (HALO) Stock Price | Nasdaq
Halozyme Therapeutics Inc (HALO) Stock Quote, History and News - Yahoo Finance
Halozyme Therapeutics Inc (HALO) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...